PYC 5.71% 18.5¢ pyc therapeutics limited

Ann: RP11 Clinical Trial Progressing To High Dose Cohort, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 652 Posts.
    lightbulb Created with Sketch. 78
    I am pretty confident that PYC will go for a 4th Cohort, as the 75 microgram dose has the potential to be quite strategic and that is why PYC want to do it.

    Shri commented back in September that PYC would 'fight' for a 100 microgram dose, however more recently Rohan indicated that PYC have their eyes on a 4th cohort at 75 micrograms.

    IMO PYC have being weighing up what sort of readouts such a cohort may deliver and balancing that against the FDA's appetite to provide the green light to go ahead, at an appropriate time. I expect that the appropriate time for such discussions would not precede the Safety Committee's approval of the 3rd cohort.

    So in short, I think it will probably happen however it may be a little further down the track. If it works the way we wish, it will be a good thing for PYC and all concerned.
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
0.010(5.71%)
Mkt cap ! $863.2M
Open High Low Value Volume
17.5¢ 18.5¢ 17.5¢ $2.060M 11.17M

Buyers (Bids)

No. Vol. Price($)
1 100000 18.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 156424 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.